112 related articles for article (PubMed ID: 8837061)
41. Bradykinin increases the permeability of the blood-tumor barrier by the caveolae-mediated transcellular pathway.
Liu LB; Xue YX; Liu YH
J Neurooncol; 2010 Sep; 99(2):187-94. PubMed ID: 20146088
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
Sasaki Y; Tamura T; Eguchi K; Shinkai T; Fujiwara Y; Fukuda M; Ohe Y; Bungo M; Horichi N; Niimi S
Cancer Chemother Pharmacol; 1989; 23(4):243-6. PubMed ID: 2647312
[TBL] [Abstract][Full Text] [Related]
43. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
44. Selective increase in blood-tumor barrier permeability by calcium antagonists in transplanted rat brain tumors.
Matsukado K; Nomura T; Ikezaki K; Fukui M
Acta Neurochir Suppl (Wien); 1994; 60():403-5. PubMed ID: 7526626
[TBL] [Abstract][Full Text] [Related]
45. [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmoral mannitol].
Miyagami M; Kagawa Y; Tsubokawa T
No Shinkei Geka; 1985 Sep; 13(9):955-63. PubMed ID: 2999632
[TBL] [Abstract][Full Text] [Related]
46. [The effect on the tumor vessel permeability by hyperosmotic blood brain barrier disruption].
Miyagami M; Tazoe M; Kagawa Y; Tsubokawa T
No To Shinkei; 1988 Sep; 40(9):875-82. PubMed ID: 3142506
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
48. Effect of intracarotid bradykinin infusion on cerebral blood flow in dogs.
Muraishi M; Sayama T; Matsukado K; Inamura T; Ikezaki K; Morioka T; Fukui M
Neurol Res; 1999 Dec; 21(8):791-5. PubMed ID: 10596391
[TBL] [Abstract][Full Text] [Related]
49. Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion.
Hodozuka A; Sako K; Nakai H; Tomabechi M; Suzuki N; Yonemasu Y
J Neurooncol; 1993 Jan; 15(1):79-86. PubMed ID: 8455066
[TBL] [Abstract][Full Text] [Related]
50. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain.
Erdlenbruch B; Schinkhof C; Kugler W; Heinemann DE; Herms J; Eibl H; Lakomek M
Br J Pharmacol; 2003 Jun; 139(4):685-94. PubMed ID: 12812991
[TBL] [Abstract][Full Text] [Related]
51. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
52. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
[TBL] [Abstract][Full Text] [Related]
53. Effect of calcium antagonists on regional cerebral blood flow in transplanted rat brain tumors.
Matsukado K; Ikezaki K; Nomura T; Fukui M
J Neurooncol; 1996 Jan; 27(1):1-10. PubMed ID: 8699220
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological blood-brain barrier modification for selective drug delivery.
Cloughesy TF; Black KL
J Neurooncol; 1995 Nov; 26(2):125-32. PubMed ID: 8787854
[TBL] [Abstract][Full Text] [Related]
55. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model.
Britz GW; Ghatan S; Spence AM; Berger MS
J Neurooncol; 2002 Feb; 56(3):227-32. PubMed ID: 12061728
[TBL] [Abstract][Full Text] [Related]
56. Parenchymal damage in the territory of the anterior choroidal artery following supraophthalmic intracarotid administration of CDDP for treatment of malignant gliomas.
Tamaki M; Ohno K; Niimi Y; Aoyagi M; Nagashima G; Ichimura K; Hirakawa K
J Neurooncol; 1997 Oct; 35(1):65-72. PubMed ID: 9266442
[TBL] [Abstract][Full Text] [Related]
57. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
[TBL] [Abstract][Full Text] [Related]
58. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
59. Relationship between drug delivery and the intra-arterial infusion rate of SarCNU in C6 rat brain tumor model.
Takeda N; Diksic M
J Neurooncol; 1999 Feb; 41(3):235-46. PubMed ID: 10359143
[TBL] [Abstract][Full Text] [Related]
60. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms.
Rainov NG; Ikeda K; Qureshi NH; Grover S; Herrlinger U; Pechan P; Chiocca EA; Breakefield XO; Barnett FH
Hum Gene Ther; 1999 Jan; 10(2):311-8. PubMed ID: 10022555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
